Community seroprevalence of SARS-CoV-2 in children and adolescents in England, 2019–2021

Community seroprevalence of SARS-CoV-2 in children and adolescents in England, 2019–2021

<p><strong>Objective:</strong> To understand community seroprevalence of SARS-CoV-2 in children and adolescents. This is vital to understanding the susceptibility of this cohort to COVID-19 and to inform public health policy for disease control such as immunisation.</p&...

Full description

Bibliographic Details
Main Authors:	Ratcliffe, H, Tiley, KS, Andrews, N, Amirthalingam, G, Vichos, I, Morey, E, Douglas, NL, Marinou, S, Plested, E, Aley, P, Galiza, EP, Faust, SN, Hughes, S, Murray, CS, Roderick, M, Shackley, F, Oddie, SJ, Lees, T, Turner, DPJ, Raman, M, Owens, S, Turner, P, Cockerill, H, Lopez Bernal, J, Linley, E, Borrow, R, Brown, K, Ramsay, ME, Voysey, M, Snape, MD
Format:	Journal article
Language:	English
Published:	BMJ Publishing Group 2022

Similar Items

Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescents
by: Ratcliffe, H, et al.
Published: (2023)

Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescents
by: Helen Ratcliffe, et al.
Published: (2023-12-01)

Nasopharyngeal carriage of pneumococcus in children in England up to 10 years after 13-valent pneumococcal conjugate vaccine introduction: persistence of serotypes 3 and 19A and emergence of 7C
by: Tiley, KS, et al.
Published: (2022)

‘Be on the TEAM’ Study (Teenagers Against Meningitis): protocol for a controlled clinical trial evaluating the impact of 4CMenB or MenB-fHbp vaccination on the pharyngeal carriage of meningococci in adolescents
by: Carr, J, et al.
Published: (2020)

Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial
by: Shaw, RH, et al.
Published: (2022)

Use of a booster dose of capsular group C meningococcal glycoconjugate vaccine to demonstrate immunologic memory in children primed with one or two vaccine doses in infancy
by: Pace, D, et al.
Published: (2016)

Long-term seroprotection after an adolescent booster meningococcal serogroup C vaccination.
by: de Whalley, P, et al.
Published: (2013)

Long-term seroprotection after an adolescent booster meningococcal serogroup C vaccination
by: De Whalley, P, et al.
Published: (2013)

Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial
by: Stuart, ASV, et al.
Published: (2021)

Understanding paratyphoid infection: study protocol for the development of a human model of Salmonella enterica serovar Paratyphi A challenge in healthy adult volunteers.
by: McCullagh, D, et al.
Published: (2015)

Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial
by: Liu, X, et al.
Published: (2021)

Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trial.
by: Pace, D, et al.
Published: (2015)

Impact of meningococcal ACWY conjugate vaccines on pharyngeal carriage in adolescents: evidence for herd protection from the UK MenACWY programme
by: Carr, JP, et al.
Published: (2022)

Pneumococcal serotype-specific antibodies persist through early childhood after infant immunization: follow-up from a randomized controlled trial
by: Trück, J, et al.
Published: (2014)

Differences in immunization site pain in toddlers vaccinated with either the 10- or the 13-valent pneumococcal conjugate vaccine
by: Trück, J, et al.
Published: (2018)

Factors affecting the causality assessment of adverse events following immunisation in paediatric clinical trials: An online survey
by: Voysey, M, et al.
Published: (2015)

Factors influencing women’s attitudes towards antenatal vaccines, Group B Streptococcus and clinical trial participation in pregnancy: an on-line survey
by: McQuaid, F, et al.
Published: (2016)

Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study - a single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines
by: Shaw, RH, et al.
Published: (2023)

Divergent Memory B Cell Responses in a Mixed Infant Pneumococcal Conjugate Vaccine Schedule
by: Trück, J, et al.
Published: (2016)

Should Pneumococcal Serotype 3 Be Included in Serotype-Specific Immunoassays?
by: Ezra Linley, et al.
Published: (2019-01-01)

Immunogenicity of the UK group B meningococcal vaccine (4CMenB) schedule against groups B and C meningococcal strains (Sched3): outcomes of a multicentre, open-label, randomised controlled trial
by: Davis, K, et al.
Published: (2021)

Sex-dependent immune responses to infant vaccination: An individual participant data meta-analysis of antibody and memory B cells
by: Voysey, M, et al.
Published: (2016)

The importance of tetanus risk assessment during wound management
by: Sarah Collins, et al.
Published: (2015-01-01)

The antibody response following a booster with either a 10- or 13-valent pneumococcal conjugate vaccine in toddlers primed with a 13-valent pneumococcal conjugate vaccine in early infancy.
by: Trück, J, et al.
Published: (2016)

Immunogenicity and reactogenicity of a reduced schedule of a 4-component capsular group B meningococcal vaccine: a randomized controlled trial in infants
by: Valente Pinto, M, et al.
Published: (2020)

Lack of serum bactericidal activity in preschool children two years after a single dose of serogroup C meningococcal polysaccharide-protein conjugate vaccine.
by: Snape, MD, et al.
Published: (2005)

The place of the Macarian writings in the Eastern Christian tradition to AD 700
by: Plested, M
Published: (1999)

Immune responses to novel adenovirus type 26 and modified vaccinia virus Ankara-vectored ebola vaccines at 1 year
by: Winslow, R, et al.
Published: (2017)

Immunological effect of administration of sequential doses of Haemophilus influenzae type b and pneumococcal conjugate vaccines in the same versus alternating limbs in the routine infant immunisation schedule: an open-label randomised controlled trial.
by: Iro, M, et al.
Published: (2015)

Pneumococcal serotype-specific antibodies persist through early childhood after infant immunization: follow-up from a randomized controlled trial.
by: Johannes Trück, et al.
Published: (2014-01-01)

Neuroimaging in primary lateral sclerosis
by: Pioro, EP, et al.
Published: (2021)

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
by: Feng, S, et al.
Published: (2021)

Peptidoglycan architecture can specify division planes in Staphylococcus aureus
by: Turner, R, et al.
Published: (2010)

Peptidoglycan architecture can specify division planes in Staphylococcus aureus.
by: Turner, R, et al.
Published: (2010)

Memory B cell response to a PCV-13 booster in 3.5year old children primed with either PCV-7 or PCV-13.
by: Trück, J, et al.
Published: (2017)

Viral bronchiolitis management in hospitals in the UK
by: Carande, EJ, et al.
Published: (2018)

The #longcovid revolution: a reflexive thematic analysis
by: Turner, M, et al.
Published: (2023)

An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and females
by: Marchevsky, NG, et al.
Published: (2022)

Visitor management : case studies from world heritage sites /
by: Shackley, Myra
Published: (1998)

Changes to the UK childhood immunisation schedule
by: Akeju, O, et al.
Published: (2024)